Check out our latest Focus issue highlighting why the mechanisms of ageing, which contribute to cancer development, progression & treatment are so important in our rapidly ageing global population 👇

#Comment 🚨 Asghar&Chung highlight cancer applications of digital twins, integrating molecular data & drug responses to inform personalized treatment & accelerate drug development through clinical trial simulation. 📖⬇️

#Review 🚨 Henry & DeGregori @jdegregori.bsky.social‬ discuss models and methods used to study the connection between ageing and cancer, advocating advocating for the wider adoption of age-appropriate models of cancer to improve clinical translation 📖⬇️

#Perspective 🚨 Lazure and Gomes argue that metabolic changes that occur as a result of #ageing may shape tumour initiation and progression and the development of metastatic disease. ⬇️ 📖 https://bit.ly/3IkNY...#Perspective#ageingmoffittnews.bsky.social‬

NEW content online!

Perspective 🚨 Orsolya Vincze @OVincze, Thomas Pradeu &Co discuss how cancer research can be advanced using comparative oncology and call for the increased use of non-conventional model organisms to advance cancer prevention and treatment. 📖 ⬇️

Our July issue is LIVE! 🌞🥵🏖️ It features articles on: - Targeted protein degradation for cancer therapy - Advances in therapeutic cancer vaccines - The TGFβ paradox in HPV-driven cancer - The paths to metastasis Happy reading! 👇 📖 https://www.nature.c...

Our June issue is now LIVE!🌞 It features articles on: - Challenges of SCLC heterogeneity & phenotypic plasticity - The fibroinflammatory response in #cancer - Moonlighting functions of glucose metabolic enzymes & metabolites in cancer - PIPKs in cancer 📖👇 www.nature.com/nrc/volumes/...

I don't think I posted about this yet. COME WORK WITH US AT NATURE METHODS! This is a rare opportunity, and we can't wait for our new colleague. Feel free to contact me with questions.

I'll be there, so make sure you sign up for what promises to be a fantastic meeting!

What an honour to be part of this meeting! Fantastic scientists and clinicians in a fantastic setting, brainstorming how to advance this field and find life-saving cures for patients with glioblastoma.

And the moment you have all been waiting for...our top downloaded article of 2024! 👏 Well worth a read!

And just off the top spot....👇

And number 3....👇

In at number 4....

And the countdown begins again this week with number 5...👇

And in at number 6 👇 Top 5 coming next week! 👏 Exciting!

And at number 7....👇

In at number 8...👇

And in at number 9....👇

And in at number 10 is....👇

Well worth a read! Hanahan et al. argue that many normal cell types are hard-wired with latent functions that can be triggered to prevent inappropriate immune attack. An intrinsic capability that is co-opted by tumours 👇

Roughly 6,000 readers answered our poll, with many declaring that Bluesky was nicer, kinder and less antagonistic to science than X https://go.nature.com/42tH8Ai

Welcome immigrants from X interested in science to the friendlier skies of @bsky.app, as documented by a new @nature.com survey (but you already knew that 😉) "Bluesky is much better for science. There is much less toxicity, misinformation, and distractions." www.nature.com/articles/d41...

Welcoming the newest members of the #NatureReviews family @natrevbiodiv.bsky.social & @natrevcleantech.bsky.social on their launch week! You can follow them and more Reviews journals (and a few Editors) in this starter pack 🧪 go.bsky.app/KcxvQLp

I just registered for the upcoming @keystonesymposia.bsky.social tumor metabolism meeting in Vancouver! Anyone else attending?! We can chat about publishing & @natrevcancer.bsky.social!! 🤓📖✨ #KSTumorMetab25

Open our January issue just out as an early Xmas present 🎁

As a frequent user of depmap.org, I am impressed about the outstanding achievements summarized in this Nature Reviews cancer article: doi.org/10.1038/s415...

Hello #cancersky! It's official, we're here! Follow us for all things #cancerresearch and #oncology 🥳

One of the biggest questions we get is when will our journals be here. We thank you for your patience. You can now follow our journals with this starter pack!

All systems go! Come follow @natrevcancer.bsky.social & the other #NatureReviews titles 😃

#REVIEW 🚨 Kratz highlights the genetics of cancer in children, examining cancer predisposition syndromes + genes, embryonic mosaicisms & polygenic risk scores, focusing on their role in cancer prediction, prevention, surveillance & therapy. Read it 👇 bit.ly/3ZHhZAA

Includes articles from our journal @natrevcancer.bsky.social 👇 Well worth a browse!

#natureconference 🚨 I'm co-organizing a conference on Gene & Cell Therapies with Joao Monteiro #NatureMedicine, Pep Pàmies #NatureBiomedicalEngineering & @francesari.bsky.social #Nature. Come join us in Wenzhou in April! 👇more details: conferences.nature.com/event/GeneCe...

#NatureReviewsCancer December issue is LIVE! 🚨🎄❄️ It features Reviews on: - Cancer induced pre-conditioning of distant organs, - Strategies to investigate the biology of early cancer, - Precursor multiple myeloma - & a #Roadmap on mRNA splicing in the clinic bit.ly/4i3cnaG

a great opportunity to join the Nature team: we're looking for a neuroscience editor, ideally with a strong record in systems neuro: springernature.wd3.myworkdayjobs.com/SpringerNatu...

If you want to follow me and many of the other fantastic editors working across the Nature Portfolio, check out the starter park below 🫵👇

More #NatureReviewsCancer updates 🚨 We recently launched a collection on the #microbiome in cancer. While its role is still debated, the collection presents a selection of articles from #SpringerNature journals to highlight our current understandings.🧫🦠 😀👉 bit.ly/48u8WFH